HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Lannfelt Selected Research

Disease Progression

4/2002APOE genotypes and disease severity in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Lannfelt Research Topics

Disease

27Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2000
10Dementia (Dementias)
01/2017 - 02/2001
5Frontotemporal Dementia (Semantic Dementia)
02/2008 - 02/2000
3Insulin Resistance
01/2012 - 09/2008
2Atrophy
01/2017 - 02/2000
2Cognitive Dysfunction
01/2014 - 02/2008
2Stroke (Strokes)
09/2008 - 06/2000
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2001 - 02/2000
1Obesity
01/2012
1Body Weight (Weight, Body)
01/2012
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
08/2009
1Hypertension (High Blood Pressure)
09/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2008
1Disease Progression
04/2002
1Multiple Sclerosis
04/2002
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
04/2001
1Corticobasal Degeneration
04/2001
1Parkinson Disease (Parkinson's Disease)
04/2001
1Tauopathies
04/2001
1Heart Diseases (Heart Disease)
06/2000
1Schizophrenia (Dementia Praecox)
03/2000

Drug/Important Bio-Agent (IBA)

8Apolipoproteins E (ApoE)IBA
01/2010 - 06/2000
7Amyloid (Amyloid Fibrils)IBA
01/2017 - 01/2000
7ApolipoproteinsIBA
01/2010 - 03/2000
5Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2005
5CholesterolIBA
08/2009 - 11/2001
4Amyloid beta-PeptidesIBA
09/2008 - 04/2000
4Proteins (Proteins, Gene)FDA Link
05/2004 - 01/2000
3Glucose (Dextrose)FDA LinkGeneric
01/2013 - 09/2008
3Insulin (Novolin)FDA Link
01/2012 - 09/2008
22- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2013 - 01/2010
2Fatty Acids (Saturated Fatty Acids)IBA
08/2012 - 01/2012
2Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2010 - 03/2010
2Presenilin-1IBA
07/2001 - 06/2000
2tau Proteins (tau Protein)IBA
04/2001 - 11/2000
1Pemetrexed (MTA)FDA Link
01/2017
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2013
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2012
1Pharmaceutical PreparationsIBA
10/2010
1Cystatin CIBA
09/2008
1Apolipoprotein E4IBA
09/2008
1Levodopa (L Dopa)FDA LinkGeneric
02/2008
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2007
1Memantine (Namenda)FDA Link
01/2007
1Codon (Codons)IBA
05/2004
1LipidsIBA
04/2002
1Antihypertensive Agents (Antihypertensives)IBA
02/2001
1DiureticsIBA
02/2001
1Peptides (Polypeptides)IBA
04/2000
1AntibodiesIBA
04/2000
1Estrogens (Estrogen)FDA Link
03/2000
1Estrogen Receptor alphaIBA
03/2000
1Histamine (Histamine Dihydrochloride)FDA Link
03/2000
1Amino AcidsFDA Link
02/2000

Therapy/Procedure

1Immunotherapy
03/2014